Skip to content

Direct-acting antivirals bring fewer HCV-related liver transplants, better survival after transplantation, in Europe

Chiara Mazzarelli, one of the study researchers, at The International Liver Congress, 2018. Photo by Liz Highleyman.

Severe fibrosis improves in most people after hepatitis C cure but persists in a quarter

Smoking reduces survival after liver cancer diagnosis for people with viral hepatitis

Hepatitis C treatment highly effective in harder-to-treat people with HIV co-infection, Spanish real-life study shows

Nivolumab improves outcomes in liver cancer study

Bruno Sangro presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com

Curing hepatitis C with DAAs linked to 71% reduction in liver cancer

George Iaonnou presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com

Daily aspirin therapy linked to lower liver cancer risk

Image: carballo/Shutterstock.com

Maviret cures most people with HCV genotype 3 and those with cirrhosis

Steven Flamm presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com

Rapid fibrosis progression in large proportion of HIV-positive gay men after acute HCV